🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Site US0006
Start Date
2014-10-14
Trial ID
NCT02175433
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and prel...
Status
Active Not Recruiting
Location
University of Alabama At Birmingham
Start Date
2021-02-23
Trial ID
NCT04279847
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
VK-2019-001 is a 1/2a trial of the oral EBNA-1 targeting agent VK-2019 in p...
Status
Terminated
Location
Stanford University, School of Medicine, Stanford Cancer Institute
Start Date
2019-04-04
Trial ID
NCT03682055
Treatments Being Tested
This first-in-human study will evaluate the recommended dose for further cl...
Status
Terminated
Location
Sarah Cannon Research Institute - TN Oncology
Start Date
2020-06-19
Trial ID
NCT04441099
Treatments Being Tested
This trial will look at a drug called SEA-CD70 with and without azacitidine...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-08-07
Trial ID
NCT04227847
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, pharmacoki...
Status
Active Not Recruiting
Location
Anhui Procincial hospital
Start Date
2019-06-03
Trial ID
NCT03913949
Treatments Being Tested
Part A of this study evaluates iopofosine I 131 (CLR 131) in patients with ...
Status
Active Not Recruiting
Location
Cellectar Biosciences site
Start Date
2017-07-26
Trial ID
NCT02952508
Treatments Being Tested